The 35% CO2 inhalation panic challenge in early clinical anxiolytic drug development: Addressing current methodological limitations
Psychiatry Research Communications · 2026-12 · 6 (4) · 100286
DOI: 10.1016/j.psycom.2026.100286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatry Research Communications, 2026-12. Verfasst von Asso Safai Pour und 7 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for Human Drug Research Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Center for Human Drug Research Foundation
Zitieren
APA
Pour, A. S., Kam, M. L. D., Heuvel, I. V., Ballieux, B. E., Schruers, K. R., Borghans, L., Gerven, J. M. V., & Jacobs, G. E. (2026). The 35% CO2 inhalation panic challenge in early clinical anxiolytic drug development: Addressing current methodological limitations. Psychiatry Research Communications, 6(4), 100286. https://doi.org/10.1016/j.psycom.2026.100286
Vancouver
Pour AS, Kam MLD, Heuvel IV, Ballieux BE, Schruers KR, Borghans L, et al. The 35% CO2 inhalation panic challenge in early clinical anxiolytic drug development: Addressing current methodological limitations. Psychiatry Research Communications. 2026;6(4):100286. doi:10.1016/j.psycom.2026.100286
BibTeX
@article{Pour2026,
author = {Pour, Asso Safai and Kam, Marieke L. de and Heuvel, Ingrid van and Ballieux, Bart E.P.B. and Schruers, Koen R.J. and Borghans, Laura and Gerven, Joop M.A. van and Jacobs, Gabriel E.},
title = {The 35% CO2 inhalation panic challenge in early clinical anxiolytic drug development: Addressing current methodological limitations},
journal = {Psychiatry Research Communications},
year = {2026},
volume = {6},
number = {4},
pages = {100286},
doi = {10.1016/j.psycom.2026.100286}
}
EUVIMED